Fall 2023 Springboard Research & Scholarship Awards

Congratulations to the individuals and teams from the School of Medicine who were selected for awards
06/08/2020 - Boston, Mass. - The lettering above the Medical Education Building at the Tufts University School of Medicine on June 8, 2020. (Alonso Nichols/Tufts University)

We are delighted to announce award decisions for the Fall 2023 cycle of the Research & Scholarship program of Tufts Springboard, sponsored by the Office of the ProvostOffice of the Vice Provost for Research (OVPR), and Tufts Medicine. Each of these high-quality, high-impact research, scholarship, and educational initiatives contributes to vibrant research at Tufts by having an explicit plan leading to extramural funding or other outcomes that further influence research, scholarship, and/or policy.

These grants represent a significant investment in the future vitality of Tufts as a thriving R1, very-high research activity university. In keeping with this cycle’s emphasis on supporting Tufts’ racial justice efforts, many of the projects focused on highlighting racial inequities and promoting access and equity.

Please join us in congratulating the following individuals/teams who were selected for awards:

TIER 2

Identification of Clinically Important Babesia Microti Antigens in Human Erythrocytes
Team Lead: Athar Chishti (TUSM)
Team Member: Toshihiko Hanada (TUSM)

Defining the Role of RIPK1 Kinase in Astrocyte-induced Loss of Blood-brain Barrier Integrity
Team Leads: Alexei Degterev (TUSM), Miranda Good (Tufts Medicine), and Yongjie Yang (TUSM)

Examining the Impact of Racial Colorblindness among Healthcare Professionals on the Referral of Racial Minorities in Clinical Research Studies
Team Lead: Jennifer Kim (TUSM)
Team Members: Keith Maddox (A&S) and Madison Ford (TUSM)

How Father's Stress Impacts Neonatal Growth and Metabolism via the Placenta
Team Leads: Perrie Faye O'Tierney-Ginn (Tufts Medicine, TUSM) and Larry Feig (TUSM)
Team Members: Robert Sege (Tufts Medicine, TUSM), Erika Werner (Tufts Medicine, TUSM), Taysir Mahmoud (Tufts Medicine), and Francesca Carasi-Schwartz (Tufts Medicine)

TIER 3

Evaluating the Feasibility of a Multidisciplinary Community Health Intervention on Lung Cancer Screening Rates in Massachusetts
Team Lead: Kimberly Dong (TUSM)
Team Members: Archita Goyal (TUSM), Hannah Edenbaum (TUSM), Kenneth Chui (TUSM), Jane Luangrath (Community Action Programs Inter-City), and Keishla Diaz-Hernandez (Community Action Programs Inter-City)